Díaz-Rubio, E., Gómez-España, A., Massutí, B., Sastre, J., Reboredo, M., Manzano, J. L., . . . Bando, I. (2012). Role of Kras Status in Patients with Metastatic Colorectal Cancer Receiving First-Line Chemotherapy plus Bevacizumab: A TTD Group Cooperative Study. Public Library of Science.
Styl ChicagoDíaz-Rubio, Eduardo, et al. Role of Kras Status in Patients With Metastatic Colorectal Cancer Receiving First-Line Chemotherapy Plus Bevacizumab: A TTD Group Cooperative Study. Public Library of Science, 2012.
Citace podle MLADíaz-Rubio, Eduardo, et al. Role of Kras Status in Patients With Metastatic Colorectal Cancer Receiving First-Line Chemotherapy Plus Bevacizumab: A TTD Group Cooperative Study. Public Library of Science, 2012.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..